Lesine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lesine

What is Lesine? Overview and Classification

Property Description
Active ingredient Drospirenone and Ethinyl Estradiol
Form Oral film-coated tablet (Monophasic)
Pharmacological class Combined Hormonal Contraceptive (CHC)
Common use Prevention of pregnancy (Hormonal Contraception)
Origin Synthetic steroid hormones
Distinguishing Feature Contains Drospirenone, a progestin with anti-androgenic activity

Lesine is a Prescription-Only Medicine (POM) that is classified as a Combined Hormonal Contraceptive (CHC). This places it in the pharmacological class of Estrogen-Progestin Combinations, specifically formulated for systemic use. As a monophasic combination product, Lesine is consistently delivered as an oral tablet, representing a documented form of hormonal regulation.

The drug entity is designed for systemic action via the oral route of administration. The foundation of this medicine’s identity is the presence of its two active ingredients: the synthetic progestogen Drospirenone and the synthetic estrogen Ethinyl Estradiol. This specific combination is clinically recognized for its efficacy in fertility management.

Composition and Primary Purpose

The active ingredient composition is crucial, as Drospirenone offers a notable differentiation from older progestins. Unlike earlier generations, drospirenone is a spironolactone analogue, structurally conferring anti-androgenic properties. This characteristic is relevant for patients, as progestins with this profile are associated with improved tolerability.

The combination with Ethinyl Estradiol ensures the primary contraceptive effect is achieved through coordinated hormonal signaling. The core purpose of Lesine is Hormonal Contraception, providing a method for the prevention of pregnancy in women of reproductive age. The systemic delivery of these synthetic hormones achieves the general therapeutic effect of suppressing the processes required for conception.

Regulatory References

  1. National Institutes of Health (NIH)
  2. NIH, Birth Control Overview

What side effects are possible with Lesine?

Possible side effects and safety information

The medicine's safety profile is defined by officially classified adverse reactions and key safety constraints documented in regulatory labeling. Side effects are categorized by frequency, ranging from Very Common to Rare, which establishes the expected pattern of adverse events during use.


Adverse Reactions by Frequency and System-Organ Class

The most frequently reported effects are classified as Very Common and include headache and breast pain/tenderness. Effects classified as Common include nausea, vomiting, mood changes (including depression), decreased libido, and menstrual irregularities such as spotting or irregular bleeding. These effects often manifest during the initial phase of treatment.


Serious Adverse Reactions and Safety Constraints

The official safety information highlights the risk of Rare but serious vascular events, including Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE), such as stroke or myocardial infarction. Regulatory documents note that the risk of VTE is highest during the first year of use.

Due to the drospirenone component, a risk of Hyperkalaemia (high potassium levels) is noted. For this reason, the medicine is contraindicated in individuals with severe renal impairment, adrenal insufficiency, or severe hepatic impairment as these conditions increase the safety risk. Furthermore, the risk of serious cardiovascular events is notably increased in specific populations, such as women over 35 years old who smoke.

Overdose and Emergency Response

Lesine Overdose and When to Seek Help

Overdosage with Drospirenone and Ethinyl Estradiol (Lesine) necessitates immediate attention and specific monitoring protocols, as mandated by official regulatory documents.

Documented Overdose Manifestations

The officially documented clinical presentations of overdosage are specific and generally non-severe. These manifestations include the occurrence of nausea and the presence of withdrawal bleeding in females. Regulatory safety documentation emphasizes that there have been no reports of serious ill effects from overdose, including those cases involving accidental ingestion by children. This explicitly documented low acute toxicity profile indicates that severe or life-threatening outcomes are not typically associated with overdosage of this product.

Required Emergency Response and Monitoring

Immediate medical attention must be sought following any suspected overdose. Contacting emergency medical services or a poison help line is the mandated action to ensure prompt clinical evaluation and oversight.

Management for an overdose is officially classified as symptomatic and supportive. Due to the anti-mineralocorticoid properties of the drospirenone component, specific hospital monitoring is required. This surveillance involves checking serum concentrations of potassium and sodium, and looking for evidence of metabolic acidosis. These specific blood chemistry checks are essential for guiding necessary supportive care, as no specific antidote is known for this combination medicine.

Therapeutic Uses of Lesine

What Lesine Treats: Main Uses and Benefits

The therapeutic application of Drospirenone/Ethinyl Estradiol (Lesine) is focused on two main symptomatic domains: managing fertility for the purpose of pregnancy prevention and addressing specific hormonally-driven conditions that may affect functional stability. This combination is commonly used for the prevention of pregnancy, moderate acne, and the symptoms of PMDD.


Fertility Control and Cycle Quality Support

Lesine's primary use is in managing fertility for the purpose of pregnancy prevention. This continuous application also contributes to benefits related to the menstrual cycle. It helps manage symptoms related to physical discomfort, such as painful periods (dysmenorrhea), and is used to help manage the burden of excessive flow, which supports predictable and manageable cyclical patterns that may support day-to-day comfort and functional stability.


Management of Hormonally-Sensitive Conditions

The medication is considered relevant for easing symptoms in conditions where manifestations are responsive to this combination hormone therapy. It is commonly used to help with Premenstrual Dysphoric Disorder (PMDD), supporting the patient during difficult episodes by helping address the symptoms of severe cyclical emotional distress, tension, and physical discomfort associated with the luteal phase. Additionally, it may assist with treating moderate acne vulgaris, which contributes to improved comfort related to skin appearance for women who also require contraception. The key therapeutic uses this formulation helps address are prevention of pregnancy, moderate acne vulgaris, and the symptoms of PMDD.

Quick Fact: Relief for Cyclical Discomfort The formulation is applied in situations involving recurrent or episodic manifestations, providing supportive relief that helps ease the overall symptom burden of conditions like PMDD and dysmenorrhea.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Lesine? Official Regulatory Information

Official regulatory documents define strict eligibility criteria for Lesine (Drospirenone/Ethinyl Estradiol), primarily restricting use based on cardiovascular risk and specific pre-existing conditions.

Eligibility Status

Classification Eligibility Rules
Populations Allowed Females of reproductive potential who have achieved menarche. Use for moderate acne is established in females aged ge 14 years who also desire contraception.
Contraindicated Populations Females over 35 years old who smoke must not use Lesine. Individuals with a history of or current arterial or venous thrombotic diseases (e.g., DVT, stroke) or thrombophilic disorders are prohibited from use.
Specific Condition Restrictions Contraindicated in patients with hepatic impairment, renal impairment, or adrenal insufficiency. Use is prohibited in those with uncontrolled hypertension or known or suspected hormone-sensitive cancers.

Reproductive and Age Limitations

Lesine is contraindicated during known or suspected pregnancy. Use is not recommended during lactation. The medicine is not indicated for use in women who have not reached menarche or who are postmenopausal. Use must also be temporarily discontinued before and after major surgery or during periods of prolonged immobilization.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory interaction profile for Lesine (Drospirenone/Ethinyl Estradiol) is defined by two primary concerns: the pharmacokinetic influence of metabolic enzyme modulation and the pharmacodynamic risk of hyperkalemia.

Co-administration is formally contraindicated with certain Hepatitis C combination products, specifically those containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for significant liver enzyme elevations. Use is also contraindicated in females over 35 years of age who smoke, as the hormonal components interact with smoking to severely increase cardiovascular risk.

Pharmacokinetic Interactions involve substances that alter the plasma concentrations of Lesine's hormones. Strong or moderate CYP3A4 inducers (e.g., rifampin, St. John's Wort) may decrease the plasma concentrations of the hormonal components, risking reduced effectiveness. Conversely, potent CYP3A4 inhibitors (e.g., ketoconazole) significantly increase the systemic exposure of drospirenone.

Due to drospirenone’s anti-mineralocorticoid activity, a pharmacodynamic interaction exists with agents that raise serum potassium, such as ACE inhibitors, potassium-sparing diuretics, and potassium supplements. This combination carries an increased risk of hyperkalemia and requires the monitoring of serum potassium concentration during the first cycle. This interaction is exacerbated in certain populations, making the product contraindicated in patients with pre-existing renal impairment, hepatic impairment, or adrenal insufficiency.

Mechanism of Action

Targeted Inhibition of Renal Uric Acid Transporters

Lesine exerts its mechanism of action by functioning as an inhibitor and antagonist for two specific transport proteins located on kidney cells: Uric Acid Transporter 1 ( URAT1) and Organic Anion Transporter 4 ( OAT4) . This action is localized to the renal proximal tubules, where the drug physically binds to and blocks the transport mechanism responsible for moving uric acid from the filtered urine back into the systemic circulation.

Effect on Uric Acid Excretion Pathway

By interfering with the reabsorption process, Lesine modulates the renal urate excretion pathway. This inhibition prevents the body from retaining the metabolite and leads to an enhanced elimination of uric acid through the urine, a process known as uricosuria. This key physiological effect results directly in a reduction in the concentration of uric acid in the systemic circulation, which constitutes the drug's total pharmacodynamic effect.

Dosage and Administration Information

How Lesine is Used in Clinical Practice

Lesine is used as a monophasic, 28-day oral cyclical regimen for the prevention of pregnancy and for the management of approved non-contraceptive indications, such as moderate acne and the symptoms of Premenstrual Dysphoric Disorder (PMDD). The administration method is designed to maintain systemic hormone levels for consistent regulation.

Official Administration Guidelines

Parameter Instruction
Route of Administration The approved route for Lesine is oral.
Dosing Schedule One tablet daily for 28 consecutive days, immediately followed by a new pack. The regimen typically consists of 24 active tablets (hormone-containing) and 4 inert tablets (hormone-free).
Timing and Food The tablet must be taken at the same time each day. It may be administered with or without food.

Procedural Structure and Contextual Rules

Proper use is dictated by following the specific order of tablets as indicated on the blister pack, beginning with the active tablets and concluding with the inert ones. The regimen is intended for long-term, continuous cyclic use for fertility control. Specific rules govern the initiation of therapy, such as beginning use no sooner than four weeks postpartum for non-breastfeeding women.

Missed Active Tablets: There is a defined protocol for missed active doses, which may require the use of backup barrier contraception for a specified period, depending on the week the dose was missed, to maintain the integrity of the regimen. Similarly, a gastrointestinal event, such as severe vomiting or diarrhea within three to four hours of administration, is managed as a potential missed dose, necessitating immediate procedural follow-up.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lesine

This section provides an overview of the clinical research conducted for Lesine (Drospirenone/Ethinyl Estradiol), focusing on the types of studies performed, the data that was measured, and what remains to be established according to regulatory and peer-reviewed sources.


Evidence for Use in Pregnancy Prevention (Contraception)

Research exploring the use of Lesine for pregnancy prevention consists of large, multi-center Randomized Controlled Trials (RCTs) and long-term observational studies. These studies examined the product's data collected and cycle-related patterns in women of reproductive age. Studies reported patterns regarding pregnancy rates using standardized measurements like the Pearl Index. The research landscape for this use is classified as having a high level of evidence.

What remains uncertain is primarily related to the very long-term health patterns, as data spanning many years is still emerging and heavily relies on large observational settings. The data collected will always differ between the highly structured conditions of a clinical trial and typical individual use.


Evidence for Managing Symptoms of Premenstrual Dysphoric Disorder (PMDD)

Research exploring the use of Lesine for Premenstrual Dysphoric Disorder (PMDD) symptoms was conducted using double-blind, placebo-controlled RCTs. These trials were evaluated in women with a confirmed PMDD diagnosis and were studied for the purpose of evaluating symptom patterns associated with this condition, using validated scales. The evidence supporting this indication is classified as having a high level.

Long-term effects are not fully established, as follow-up durations were limited, typically restricted to three to six treatment cycles. Interpreting results is complex due to a noticeable placebo effect that was observed during the study period.


Evidence for Managing Moderate Acne Vulgaris

The research base for moderate acne vulgaris is built on Randomized Controlled Trials (RCTs). These trials focused on outcomes linked to inflammatory states and included objective measures such as counting the change in the number of lesions. The evidence quality for this indication is classified as having a high level.

Research is ongoing to provide more insight into how positive patterns last over extended periods, as the primary study duration of six months is an intermediate timeframe for a dermatological condition. Limited comparative evidence is lacking against all non-hormonal, gold-standard acne treatments.

Frequently Asked Questions (FAQ)

Common questions about Lesine (FAQ)

Q: What is the mechanism of action of Lesine?

A: According to official product information, Lesine is a combined hormonal contraceptive. Its primary effects for pregnancy prevention are described as the inhibition of ovulation, the thickening of cervical mucus, and changes to the lining of the uterus.

Q: Will I feel Lesine working right away, or does it take time?

A: Official information indicates that contraceptive effectiveness is not considered established immediately upon starting the medicine. Protection is generally not considered achieved until after the first 7 consecutive days of active tablet administration.

Q: How long does the effect of one dose of Lesine last?

A: Lesine is designed as a treatment that requires a daily dose to be effective. The regimen is based on taking the tablet at the same time every day to maintain the consistent level of hormones necessary for a continuous therapeutic effect.

Q: Is it possible for Lesine to stop working over time?

A: The efficacy of the medicine relies heavily on consistent, correct daily administration. Official labeling indicates that the risk of contraceptive failure may increase when tablets are missed.

Q: Why do some people need to take Lesine for months before they see a change?

A: For non-contraceptive uses, such as for acne and the symptoms of PMDD, the effects are not immediate. The clinical trials used to establish the medicine's effectiveness for these conditions typically evaluated outcomes over three to six treatment cycles before final results were measured.

Q: Do the side effects of Lesine go away after I've been taking it for a while?

A: Official documents note that the most frequently reported adverse effects, such as headache or nausea, often manifest during the initial phase of treatment. This timeframe represents the initial phase of administration.

Q: What are the most common side effects people report online for Lesine?

A: Based on clinical trial data summarized in official labeling, the most commonly reported side effects include headache, nausea, breast pain or tenderness, and irregular menstrual periods (like spotting).

Q: Is Lesine generally safe for older adults or seniors?

A: Official regulatory information states that this medicine is not indicated for use in postmenopausal women. Contraindications also restrict use for females over 35 years old who smoke due to increased cardiovascular risk. Safety is restricted to women of reproductive age.

Q: Can Lesine cause weight gain or loss?

A: Official documents on adverse reactions note that change in weight or appetite (either an increase or decrease) and weight increased are reported as possible side effects associated with the medicine.

Q: Does Lesine affect mood or cause any kind of anxiety?

A: Official prescribing information notes that mood changes, including depression, are possible adverse reactions. However, official regulatory documents do not list anxiety as one of the common or very common side effects.

Q: Can Lesine be taken with pain relievers like ibuprofen or acetaminophen?

A: Caution is advised when using this medicine with other drugs that can increase serum potassium levels. This class includes certain Nonsteroidal Anti-inflammatory Drugs (NSAIDs), especially with chronic use.

Q: Do common supplements, like vitamins or herbal products, interact with Lesine?

A: The herbal product St. John’s Wort is specifically cited in official documents as potentially decreasing the contraceptive effectiveness of this medicine. You should mention any supplements to a healthcare provider for review.

Q: What should I do if I notice a change in my period cycle while on Lesine?

A: Irregular bleeding or spotting is a common and expected side effect, especially when starting the medication. Official labeling advises patients to continue taking the tablets regularly as scheduled and to inform their healthcare provider if this occurs.

Q: Does Lesine affect fertility in men or women?

A: This medicine is used for the prevention of pregnancy. Studies indicate that fertility is understood to return after the medicine is discontinued, although some women may experience a temporary delay in the return of a regular menstrual cycle.

Q: Is it normal to feel a bit tired when starting Lesine?

A: Fatigue (low energy or tiredness) is noted in official regulatory summaries as a possible adverse reaction. If fatigue is unexplained or severe, it is a pattern that should be noted by a healthcare provider.

Q: What happens if I take Lesine with caffeine or energy drinks?

A: Official drug monographs note that the use of this medicine with caffeine may potentially cause an increased risk of certain side effects. Monitoring your overall caffeine intake is a consideration when using this medicine.

Q: Does taking Lesine mean I need to get blood tests done regularly?

A: Monitoring of serum potassium concentration is required during the first cycle for women taking co-administered medications that may increase potassium levels. Monitoring is also noted for women who have certain metabolic conditions.

Q: Is Lesine affected by alcohol consumption?

A: Official drug monographs state that alcohol may cause interactions with certain medicines, but no specific contraindication is listed for this medicine.

Q: If I miss a day of Lesine, does that ruin the whole process?

A: Missing one pill does not necessarily 'ruin' the process, as official labeling provides a specific protocol for missed doses. However, the risk of pregnancy increases with each active tablet missed. Official labeling provides specific information regarding the use of backup contraception based on the number and timing of missed tablets.

Q: Are there specific symptoms that mean I should stop taking Lesine?

A: Discontinuation is required if a thrombotic event occurs. Regulatory warnings advise patients that symptoms of a serious event, such as a blood clot, warrant immediate attention.

Q: What is the general success rate or evidence theme reported for Lesine?

A: When taken consistently and correctly as studied, the failure rate for contraception is described as very low. Official clinical study summaries indicate the failure rate is approximately 1% per year.

Q: Why is Lesine often mentioned in discussions about hormone-related issues?

A: The medicine’s active ingredients are a combination of synthetic estrogen and progestin. Because these are female sex hormones, the medicine provides systemic hormonal regulation, linking it to the management of various hormone-related issues.

Q: Does Lesine need special storage, like keeping it in the refrigerator?

A: No, the official requirement is to store the medicine at controlled room temperature (20 C to 25 C). It is important to keep it in the original container and protect it from moisture and light.

Q: Are there any specific symptoms Lesine is not expected to help with?

A: Official documents explicitly state that this medicine has not been shown to be effective for the treatment of Premenstrual Syndrome (PMS). Its indication is limited to the more severe form of symptoms known as PMDD.

Q: What are the signs of an overdose with Lesine?

A: Symptoms associated with an overdose of this type of hormonal medicine may include nausea, vomiting, and in females, withdrawal bleeding. Any suspected overdose is a situation that warrants immediate reporting to emergency services.

Q: Are there specific tests doctors run before prescribing Lesine?

A: Before prescribing, doctors assess for known contraindications. Monitoring is specified for certain patients, such as checking serum potassium concentration during the first cycle if co-administered with certain other medications.

How should Lesine be stored and disposed of?

How to Store and Dispose of Lesine?

The storage and disposal of Lesine (drospirenone and ethinyl estradiol) must follow official regulatory requirements to ensure product quality and safe waste handling.


Storage Requirements

Item Official Regulatory Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep in the original container/blister pack to protect from moisture and light.
Safety Keep out of the sight and reach of children and pets.

Disposal Instructions

Unused or expired Lesine must be disposed of according to local guidelines. The preferred method is to utilize a drug take-back program. If a program is unavailable, the medicine may be placed in the household trash only after being mixed with an unappealing substance, like dirt or coffee grounds, and sealed in a container. Do not flush Lesine down the toilet or throw it into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lesine found in:

A-Z Index: